Product NDC: | 45802-840 |
Proprietary Name: | Levonorgestrel |
Non Proprietary Name: | Levonorgestrel |
Active Ingredient(s): | .75 mg/1 & nbsp; Levonorgestrel |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-840 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090740 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110310 |
Package NDC: | 45802-840-54 |
Package Description: | 1 BLISTER PACK in 1 CARTON (45802-840-54) > 2 TABLET in 1 BLISTER PACK |
NDC Code | 45802-840-54 |
Proprietary Name | Levonorgestrel |
Package Description | 1 BLISTER PACK in 1 CARTON (45802-840-54) > 2 TABLET in 1 BLISTER PACK |
Product NDC | 45802-840 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levonorgestrel |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20110310 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | LEVONORGESTREL |
Strength Number | .75 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC] |